209 related articles for article (PubMed ID: 24759208)
1. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins LT; Hanson D; Heneine W; García-Lerma JG
AIDS; 2014 Jun; 28(10):1431-9. PubMed ID: 24759208
[TBL] [Abstract][Full Text] [Related]
2. A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
Butler K; Ritter JM; Ellis S; Morris MR; Hanson DL; McNicholl JM; Kersh EN
J Acquir Immune Defic Syndr; 2016 Aug; 72(4):363-71. PubMed ID: 27355414
[TBL] [Abstract][Full Text] [Related]
3. Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIV
Srinivasan P; Zhang J; Dinh CT; Teller RS; McNicholl JM; Kiser PF; Herold BC; Smith JM
J Med Primatol; 2017 Aug; 46(4):129-136. PubMed ID: 28748662
[TBL] [Abstract][Full Text] [Related]
4. Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.
Butler K; Ritter J; Ellis S; Henning TR; Montague J; Zaki S; Garber D; McNicholl JM; Kersh EN
J Med Primatol; 2015 Oct; 44(5):286-95. PubMed ID: 26238265
[TBL] [Abstract][Full Text] [Related]
5. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
Bahamondes MV; Castro S; Marchi NM; Marcovici M; Andrade LA; Fernandes A; Bahamondes L
Contraception; 2014 Aug; 90(2):117-22. PubMed ID: 24613369
[TBL] [Abstract][Full Text] [Related]
6. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
[TBL] [Abstract][Full Text] [Related]
7. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
[TBL] [Abstract][Full Text] [Related]
8. Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques.
Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins L; Heneine W; García-Lerma JG
J Acquir Immune Defic Syndr; 2014 Dec; 67(4):365-9. PubMed ID: 25202923
[TBL] [Abstract][Full Text] [Related]
9. Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission.
Pullium JK; Adams DR; Jackson E; Kim CN; Smith DK; Janssen R; Gould K; Folks TM; Butera S; Otten RA
J Infect Dis; 2001 Apr; 183(7):1023-30. PubMed ID: 11237826
[TBL] [Abstract][Full Text] [Related]
10. RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.
Jiang Y; Tian B; Saifuddin M; Agy MB; Emau P; Cairns JS; Tsai CC
AIDS Res Ther; 2009 Nov; 6():23. PubMed ID: 19891783
[TBL] [Abstract][Full Text] [Related]
11. Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices.
Birse KD; Romas LM; Guthrie BL; Nilsson P; Bosire R; Kiarie J; Farquhar C; Broliden K; Burgener AD
J Infect Dis; 2017 Feb; 215(4):590-598. PubMed ID: 28011908
[TBL] [Abstract][Full Text] [Related]
12. The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques.
Daly MB; Sterling M; Holder A; Dinh C; Nishiura K; Khalil G; García-Lerma JG; Dobard C
Antiviral Res; 2021 Feb; 186():105001. PubMed ID: 33385420
[TBL] [Abstract][Full Text] [Related]
13. Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
Weinberg A; Park JG; Bosch R; Cho A; Livingston E; Aweeka F; Cramer Y; Watts DH; Luque AE; Cohn SE
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):137-45. PubMed ID: 26413850
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
[TBL] [Abstract][Full Text] [Related]
15. Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from simian HIV acquisition by long-acting cabotegravir in macaques.
Vishwanathan SA; Zhao C; Luthra R; Khalil GK; Morris MM; Dinh C; Gary MJ; Mitchell J; Spreen WR; Pereira LE; Heneine W; García-Lerma JG; McNicholl JM
AIDS; 2022 Feb; 36(2):169-176. PubMed ID: 34482355
[TBL] [Abstract][Full Text] [Related]
16. Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion.
Quispe Calla NE; Vicetti Miguel RD; Aceves KM; Torres A; Cherpes TL
Contraception; 2019 Nov; 100(5):397-401. PubMed ID: 31302121
[TBL] [Abstract][Full Text] [Related]
17. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.
Chandra N; Thurman AR; Anderson S; Cunningham TD; Yousefieh N; Mauck C; Doncel GF
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):592-601. PubMed ID: 23189932
[TBL] [Abstract][Full Text] [Related]
18. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
[TBL] [Abstract][Full Text] [Related]
19. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
Westhoff C
J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
[TBL] [Abstract][Full Text] [Related]
20. Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.
Nanda K; Callahan R; Taylor D; Wang M; Agot K; Jenkins D; Van Damme L; Dorflinger L;
Contraception; 2016 Jul; 94(1):40-7. PubMed ID: 26972780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
